<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://cardiovascularultrasound.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Cardiovascular Ultrasound - Most accessed articles</title>
        <link>http://www.cardiovascularultrasound.com</link>
        <description>The most accessed research articles published by Cardiovascular Ultrasound</description>
        <dc:date>2010-01-22T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/3/1/17" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/8/1/3" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/7/1/59" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/3/1/9" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/7/1/58" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/2/1/17" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/8/1/1" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/7/1/57" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/6/1/49" />
                                <rdf:li rdf:resource="http://www.cardiovascularultrasound.com/content/6/1/50" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/3/1/17">
        <title>Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?</title>
        <description>Left ventricular hypertrophy is an important risk factor in cardiovascular disease and echocardiography has been widely used for diagnosis. Although an adequate methodologic standardization exists currently, differences in measurement and interpreting data is present in most of the older clinical studies. Variability in border limits criteria, left ventricular mass formulas, body size indexing and other adjustments affects the comparability among these studies and may influence both the clinical and epidemiologic use of echocardiography in the investigation of the left ventricular structure. We are going to review the most common measures that have been employed in left ventricular hypertrophy evaluation in the light of some recent population based echocardiographic studies, intending to show that echocardiography will remain a relatively inexpensive and accurate tool diagnostic tool.</description>
        <link>http://www.cardiovascularultrasound.com/content/3/1/17</link>
                <dc:creator>Murilo Foppa</dc:creator>
                <dc:creator>Bruce Duncan</dc:creator>
                <dc:creator>Luis Rohde</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2005, 3:17</dc:source>
        <dc:date>2005-06-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-3-17</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2005-06-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/8/1/3">
        <title>Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography study
</title>
        <description>Background:
Isovolumetric acceleration (IVA) is a novel tissue Doppler parameter for the assessment of systolic function. The aim of this study was to evaluate IVA as an early parameter for the detection of right ventricular (RV) systolic dysfunction in patients with systemic sclerosis (SSc) without pulmonary hypertension.
Methods:
22 patients and 22 gender- and age-matched healthy subjects underwent standard echocardiography with tissue Doppler imaging (TDI) and speckle tracking strain to assess RV function.
Results:
Tricuspid annular plane systolic excursion (TAPSE) (23.2 &#177; 4.1 mm vs. 26.5 &#177; 2.9 mm, p &lt; 0.006), peak myocardial systolic velocity (Sm) (11.6 &#177; 2.3 cm/s vs. 13.9 &#177; 2.7 cm/s, p = 0.005), isovolumetric contraction velocity (IVV) (10.3 &#177; 3 cm/s vs. 14.8 &#177; 3 cm/s, p &lt; 0.001) and IVA (2.3 &#177; 0.4 m/s2 vs. 4.1 &#177; 0.8 m/s2, p &lt; 0.001) were significant lower in the patient group. IVA was the best parameter to predict early systolic dysfunction with an area under the curve of 0.988.
Conclusion:
IVA is a useful tool with high-predictive power to detect early right ventricular systolic impairment in patients with SSc and without pulmonary hypertension.</description>
        <link>http://www.cardiovascularultrasound.com/content/8/1/3</link>
                <dc:creator>Sebastian Schattke</dc:creator>
                <dc:creator>Fabian Knebel</dc:creator>
                <dc:creator>Andrea Grohmann</dc:creator>
                <dc:creator>Henryk Dreger</dc:creator>
                <dc:creator>Friederike Kmezik</dc:creator>
                <dc:creator>Gabriela Riemekasten</dc:creator>
                <dc:creator>Gert Baumann</dc:creator>
                <dc:creator>Adrian Borges</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2010, 8:3</dc:source>
        <dc:date>2010-01-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-8-3</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/7/1/59">
        <title>Relationship between carotid intima-media thickness and coronary angiographic findings: a prospective study</title>
        <description>Background:
Since cardiovascular diseases are associated with high mortality and generally undiagnosed before the onset of clinical findings, there is a need for a reliable tool for early diagnosis. Carotid intima-media thickness (CIMT) is a non-invasive marker of coronary artery disease (CAD) and is widely used in practice as an inexpensive, reliable, and reproducible method. In the current study, we aimed to investigate prospectively the relationship of CIMT with the presence and extent of significant coronary artery narrowing in patients evaluated by coronary angiography for stable angina pectoris.
Methods:
One hundred consecutive patients with stable angina pectoris and documented ischemia on a stress test were included in the study. The patients were divided into two groups according to the result of the coronary angiography: group 1 (39 patients) without a noncritical coronary lesion, and group 2 (61 patients) having at least one lesion more than 50% within the main branches of the coronary arteries. All of the patients underwent carotid Doppler ultrasound examination for measurement of the CIMT by a radiologist blinded to the angiographic data.
Results:
The mean CIMT was 0.78 &#177; 0.21 mm in Group 1, while it was 1.48 &#177; 0.28 mm in Group 2 (p = 0.001). The mean CIMT in patients with single vessel disease, multi-vessel disease, and left main coronary artery disease were significantly higher compared to Group 1 (1.2 &#177; 0.34 mm, p = 0.02; 1.6 &#177; 0.32 mm, p = 0.001; and 1.8 &#177; 0.31 mm, p = 0.0001, respectively). Logistic regression analysis identified CIMT (OR 4.3, p &lt; 0.001) and hypertension (OR 2.4, p = 0.04) as the most important factors for predicting CAD.
Conclusions:
The findings of this study show that increase in CIMT is associated with the presence and extent of CAD. In conclusion, we demonstrated the usefulness of carotid intima-media thickness in predicting coronary artery disease but large-scale studies are required to define its role in clinical practice.</description>
        <link>http://www.cardiovascularultrasound.com/content/7/1/59</link>
                <dc:creator>Ugur Coskun</dc:creator>
                <dc:creator>Ahmet Yildiz</dc:creator>
                <dc:creator>Ozlem Esen</dc:creator>
                <dc:creator>Murat Baskurt</dc:creator>
                <dc:creator>Mehmet Cakar</dc:creator>
                <dc:creator>Kadriye Orta Kilickesmez</dc:creator>
                <dc:creator>Lutfu Orhan</dc:creator>
                <dc:creator>Seyma Yildiz</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2009, 7:59</dc:source>
        <dc:date>2009-12-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-7-59</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>59</prism:startingPage>
        <prism:publicationDate>2009-12-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/3/1/9">
        <title>Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects</title>
        <description>Left ventricular (LV) diastolic dysfunction (DD) and diastolic heart failure (HF), that is symptomatic DD, are due to alterations of myocardial diastolic properties. These alterations involve relaxation and/or filling and/or distensibility. Arterial hypertension associated to LV concentric remodelling is the main determinant of DD but several other cardiac diseases, including myocardial ischemia, and extra-cardiac pathologies involving the heart are other possible causes. In the majority of the studies, isolated diastolic HF has been made equal to HF with preserved systolic function (= normal ejection fraction) but the true definition of this condition needs a quantitative estimation of LV diastolic properties. According to the position of the European Society of Cardiology and subsequent research refinements the use of Doppler echocardiography (transmitral inflow and pulmonary venous flow) and the new ultrasound tools has to be encouraged for diagnosis of DD. In relation to uncertain definitions, both prevalence and prognosis of diastolic heart failure are very variable. Despite an apparent lower death rate in comparison with LV systolic HF, long-term follow-up (more than 5 years) show similar mortality between the two kinds of HF. Recent studies performed by Doppler diastolic indexes have identified the prognostic power of both transmitral E/A ratio &lt; 1 (pattern of abnormal relaxation) and &gt; 1.5 (restrictive patterns). The therapy of LV DD and HF is not well established but ACE-inhibitors, angiotensin inhibitors, aldosterone antagonists and &#946;-blockers show potential beneficial effect on diastolic properties. Several trials, completed or ongoing, have been planned to treat DD and diastolic HF.</description>
        <link>http://www.cardiovascularultrasound.com/content/3/1/9</link>
                <dc:creator>Maurizio Galderisi</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2005, 3:9</dc:source>
        <dc:date>2005-04-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-3-9</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2005-04-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/7/1/58">
        <title>Transthoracic echocardiography for imaging of the different coronary artery segments: a feasibility study</title>
        <description>Background:
Transthoracic echocardiography (TTE) may be used for direct inspection of various parts of the main coronary arteries for detection of coronary stenoses and occlusions. We aimed to assess the feasibility of TTE to visualise the complete segments of the left main (LM), left descending (LAD), circumflex (Cx) and right (RCA) coronary arteries.
Methods:
One hundred and eleven patients scheduled for diagnostic coronary angiography because of chest pain or acute coronary syndrome had a TTE study to map the passage of the main coronary arteries. LAD, Cx and RCA were each divided into proximal, middle and distal segments. If any part of the individual segment of a coronary artery with antegrade blood flow was not visualised, the segment was labeled as not satisfactorily seen.
Results:
Complete imaging of the LM was achieved in 98% of the patients. With antegrade directed coronary artery flow, the proximal, middle and distal segments of LAD were completely seen in 96%, 95% and 91% of patients, respectively. Adding the completely seen segments with antegrade coronary flow and segments with retrograde coronary flow, the proximal, middle and distal segments of LAD were adequately visualised in 96%, 96% and 93% of patients, respectively. With antegrade directed coronary artery flow, the proximal, middle and distal segments of Cx were completely seen in 88%, 61% and 3% and in RCA in 40%, 28% and 54% of patients. Retrograde coronary artery flow was correctly identified as verified by coronary angiography in seven coronary segments, mainly in the posterior descending artery (labeled as the distal segment of RCA) and distal LAD.
Conclusions:
TTE is a feasible method for complete demonstration of coronary flow in the LM, the proximal Cx and the different segments of LAD, but less suitable for the RCA and mid and distal segments of the Cx. (ClinicalTrials.gov number NTC00281346.)</description>
        <link>http://www.cardiovascularultrasound.com/content/7/1/58</link>
                <dc:creator>Johnny Vegsundvag</dc:creator>
                <dc:creator>Espen Holte</dc:creator>
                <dc:creator>Rune Wiseth</dc:creator>
                <dc:creator>Knut Hegbom</dc:creator>
                <dc:creator>Torstein Hole</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2009, 7:58</dc:source>
        <dc:date>2009-12-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-7-58</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>58</prism:startingPage>
        <prism:publicationDate>2009-12-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/2/1/17">
        <title>Tissue Doppler echocardiography and biventricular pacing in heart failure: Patient selection, procedural guidance, follow-up, quantification of success</title>
        <description>Asynchronous myocardial contraction in heart failure is associated with poor prognosis. Resynchronization can be achieved by biventricular pacing (BVP), which leads to clinical improvement and reverse remodeling. However, there is a substantial subset of patients with wide QRS complexes in the electrocardiogram that does not improve despite BVP. QRS width does not predict benefit of BVP and only correlates weakly with echocardiographically determined myocardial asynchrony. Determination of asynchrony by Tissue Doppler echocardiography seems to be the best predictor for improvement after BVP, although no consensus on the optimal method to assess asynchrony has been achieved yet. Our own preliminary results show the usefulness of Tissue Doppler Imaging and Tissue Synchronization Imaging to document acute and sustained improvement after BVP. To date, all studies evaluating Tissue Doppler in BVP were performed retrospectively and no prospective studies with patient selection for BVP according to echocardiographic criteria of asynchrony were published yet. We believe that these new echocardiographic tools will help to prospectively select patients for BVP, help to guide implantation and to optimize device programming.</description>
        <link>http://www.cardiovascularultrasound.com/content/2/1/17</link>
                <dc:creator>Fabian Knebel</dc:creator>
                <dc:creator>Rona Reibis</dc:creator>
                <dc:creator>Hansjurgen Bondke</dc:creator>
                <dc:creator>Joachim Witte</dc:creator>
                <dc:creator>Torsten Walde</dc:creator>
                <dc:creator>Stephan Eddicks</dc:creator>
                <dc:creator>Gert Baumann</dc:creator>
                <dc:creator>Adrian Borges</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2004, 2:17</dc:source>
        <dc:date>2004-09-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-2-17</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2004-09-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/8/1/1">
        <title>Preoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography.</title>
        <description>Background:
This study was conducted to assess the accuracy of harmonic imaging 2D-transthoracic echocardiography (2D-TTE) segmental analysis compared to surgical findings, in degenerative mitral regurgitation (MR).
Methods:
Seventy-seven consecutive patients with severe degenerative MR were prospectively enrolled. Preoperative 2D-TTE with precise localization of prolapsing or flailing scallops/segments was performed. All patients underwent mitral valve surgical repair. Surgical reports (SR), including valve description, were used as references for comparisons. A postoperative control 2D-TTE was performed.
Results:
Out of 462 scallops/segments studied, surgical inspection identified 102 prolapses or flails (22%), 92 of which had previously been detected by 2D-TTE (90.2% sensitivity, 100% specificity). Agreement between preoperative 2D-TTE segmental analysis and SR was 97.8% (k = 0.93; p &lt; 0.0001). Sixty-nine out of 77 2D-TTE reports were completely concordant with SR (89.6% diagnostic accuracy). None of the 8 non-concordant 2D-TTE reports were in complete disagreement with SR. P2 scallop was always involved in posterior leaflet prolapse or flail and was described correctly by 2D-TTE in 68 out of 69 patients (98,7% agreement, k = 0,93; 98.5% sensitivity). The anterior leaflet was involved in 14 patients (18%); A2 segment was involved in all of those cases and was correctly detected by 2D-TTE in 13 (98,7% agreement, k = 0,95; 92,8% sensitivity). Antero-lateral and postero-medial para-commissural prolapse or flail had a lower prevalence (14% and 10% respectively), with 2D-TTE sensitivity respectively of 64% and 50%.
Conclusions:
2D-TTE, performed by an experienced echo-lab, has very good diagnostic accuracy in localizing the scallops/segments involved in degenerative MR, particularly for the middle ones (P2-A2), which represent almost the totality of prolapses. More invasive, time consuming and expensive exams should be reserved to selected cases.</description>
        <link>http://www.cardiovascularultrasound.com/content/8/1/1</link>
                <dc:creator>Giovanni Minardi</dc:creator>
                <dc:creator>Paolo Pino</dc:creator>
                <dc:creator>Carla Manzara</dc:creator>
                <dc:creator>Giovanni Pulignano</dc:creator>
                <dc:creator>Giulio Stefanini</dc:creator>
                <dc:creator>Giuseppe Viceconte</dc:creator>
                <dc:creator>Stefania Leonetti</dc:creator>
                <dc:creator>Andrea Madeo</dc:creator>
                <dc:creator>Carlo Gaudio</dc:creator>
                <dc:creator>Francesco Musumeci</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2010, 8:1</dc:source>
        <dc:date>2010-01-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-8-1</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/7/1/57">
        <title>Assessing functional mitral regurgitation with exercise echocardiography: rationale and clinical applications</title>
        <description>Secondary or functional mitral regurgitation (FMR) represents an increasing feature of mitral valve disease characterized by abnormal function of anatomically normal leaflets in the context of the impaired function of remodelled left ventricles. The anatomic and pathophysiological basis of FMR are briefly analyzed; in addition, the role of exercise echocardiography for the assessment of FMR is discussed in view of its relevance to clinical practice.</description>
        <link>http://www.cardiovascularultrasound.com/content/7/1/57</link>
                <dc:creator>Riccardo Bigi</dc:creator>
                <dc:creator>Lauro Cortigiani</dc:creator>
                <dc:creator>Francesco Bovenzi</dc:creator>
                <dc:creator>Cesare Fiorentini</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2009, 7:57</dc:source>
        <dc:date>2009-12-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-7-57</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>57</prism:startingPage>
        <prism:publicationDate>2009-12-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/6/1/49">
        <title>Echocardiography practice, training 
and accreditation in the intensive care:                        document for the World Interactive Network Focused on Critical UltraSound (WINFOCUS)
</title>
        <description>Echocardiography is increasingly used in the management of the critically ill patient as a non-invasive diagnostic and monitoring tool. Whilst in few countries specialized national training schemes for intensive care unit (ICU) echocardiography have been developed, specific guidelines for ICU physicians wishing to incorporate echocardiography into their clinical practice are lacking. Further, existing echocardiography accreditation does not reflect the requirements of the ICU practitioner. The WINFOCUS (World Interactive Network Focused On Critical UltraSound) ECHO-ICU Group drew up a document aimed at providing guidance to individual physicians, trainers and the relevant societies of the requirements for the development of skills in echocardiography in the ICU setting. The document is based on recommendations published by the Royal College of Radiologists, British Society of Echocardiography, European Association of Echocardiography and American Society of Echocardiography, together with international input from established practitioners of ICU echocardiography. The recommendations contained in this document are concerned with theoretical basis of ultrasonography, the practical aspects of building an ICU-based echocardiography service as well as the key components of standard adult TTE and TEE studies to be performed on the ICU. Specific issues regarding echocardiography in different ICU clinical scenarios are then described.Obtaining competence in ICU echocardiography may be achieved in different ways &#8211; either through completion of an appropriate fellowship/training scheme, or, where not available, via a staged approach designed to train the practitioner to a level at which they can achieve accreditation. Here, peri-resuscitation focused echocardiography represents the entry level &#8211; obtainable through established courses followed by mentored practice. Next, a competence-based modular training programme is proposed: theoretical elements delivered through blended-learning and practical elements acquired in parallel through proctored practice. These all linked with existing national/international echocardiography courses. When completed, it is anticipated that the practitioner will have performed the prerequisite number of studies, and achieved the competency to undertake accreditation (leading to Level 2 competence) via a recognized National or European examination and provide the appropriate required evidence of competency (logbook). Thus, even where appropriate fellowships are not available, with support from the relevant echocardiography bodies, training and subsequently accreditation in ICU echocardiography becomes achievable within the existing framework of current critical care and cardiological practice, and is adaptable to each countrie&apos;s needs.</description>
        <link>http://www.cardiovascularultrasound.com/content/6/1/49</link>
                <dc:creator>Susanna Price</dc:creator>
                <dc:creator>Gabriele Via</dc:creator>
                <dc:creator>Erik Sloth</dc:creator>
                <dc:creator>Fabio Guarracino</dc:creator>
                <dc:creator>Raoul Breitkreutz</dc:creator>
                <dc:creator>Emanuele Catena</dc:creator>
                <dc:creator>Daniel Talmor</dc:creator>
                <dc:creator>World Interactive Network Focused On Critical UltraSound ECHO-ICU Group (WINFOCUS ECHO-ICU Group)</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2008, 6:49</dc:source>
        <dc:date>2008-10-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-6-49</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>49</prism:startingPage>
        <prism:publicationDate>2008-10-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiovascularultrasound.com/content/6/1/50">
        <title>Persistent left superior vena cava: a case report and review of literature</title>
        <description>Persistent left superior vena cava is rare but important congenital vascular anomaly. It results when the left superior cardinal vein caudal to the innominate vein fails to regress. It is most commonly observed in isolation but can be associated with other cardiovascular abnormalities including atrial septal defect, bicuspid aortic valve, coarctation of aorta, coronary sinus ostial atresia, and cor triatriatum. The presence of PLSVC can render access to the right side of heart challenging via the left subclavian approach, which is a common site of access utilized when placing pacemakers and Swan-Ganz catheters. Incidental notation of a dilated coronary sinus on echocardiography should raise the suspicion of PLSVC. The diagnosis should be confirmed by saline contrast echocardiography.</description>
        <link>http://www.cardiovascularultrasound.com/content/6/1/50</link>
                <dc:creator>Sandeep Goyal</dc:creator>
                <dc:creator>Sujeeth Punnam</dc:creator>
                <dc:creator>Gita Verma</dc:creator>
                <dc:creator>Frederick Ruberg</dc:creator>
                <dc:source>Cardiovascular Ultrasound 2008, 6:50</dc:source>
        <dc:date>2008-10-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-7120-6-50</dc:identifier>
        <prism:publicationName>Cardiovascular Ultrasound</prism:publicationName>
        <prism:issn>1476-7120</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>50</prism:startingPage>
        <prism:publicationDate>2008-10-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
